Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 6
Treatment-assignment count: 0
Stratification count: 0
Trial Selection Rising
NTRK fusion
NSCLC · Combination Therapy
NTRK fusion is flagged as trial selection rising because public trials show inclusion required evidence in 6 contexts. FDA CDx context should be reviewed manually.
Threshold snippets
Fragmentation view
Threshold count: 5
Common snippets: BRAF V600E | BRAF V600E | KRAS G12C
Threshold label: Moderate
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Not Found
CDx maturity score: 1/5
Confidence: High
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT05241873 | https://clinicaltrials.gov/study/NCT06182761 | https://clinicaltrials.gov/study/NCT05200481 | https://clinicaltrials.gov/study/NCT07227025 | https://clinicaltrials.gov/study/NCT06970132 | https://clinicaltrials.gov/study/NCT04105270